Comment on “A Single Institution Experience With Immediate Lymphatic Reconstruction: Impact of Insurance Coverage on Risk Reduction”

We read with great interest the article by Huang et al. titled "A Single Institution Experience With Immediate Lymphatic Reconstruction: Impact of Insurance Coverage on Risk Reduction" published in the Journal of Surgical Oncology [1]. The authors provide valuable insights into the disparities in access to immediate lymphatic reconstruction (ILR) and its impact on breast cancer-related lymphedema (BCRL) outcomes. While the study highlights important issues related to insurance coverage and socioeconomic barriers, we would like to offer several suggestions to further strengthen the findings and provide additional context for future research. The study effectively demonstrates that insurance coverage significantly impacts access to ILR, particularly for patients with Medicaid or lower socioeconomic status. However, the discussion could be expanded to include a broader analysis of how insurance policies vary across different states and insurers. For instance, a 2022 study by Finkelstein et al. found that nearly half of insurers in the United States lack publicly available policies on lymphedema treatments, leading to inconsistent coverage and reimbursement for procedures like ILR [2]. This study could be referenced to emphasize the systemic nature of the problem and the need for standardized insurance policies. The authors briefly mention the lack of Current Procedural Terminology (CPT) codes for ILR as a barrier to insurance coverage. This is a critical issue that warrants further discussion. The absence of specific CPT codes for ILR makes it easier for insurers to deny coverage, as the procedure is not formally recognized in billing systems. A 2021 study by Johnson et al. highlighted the challenges of obtaining reimbursement for ILR due to the lack of standardized coding, which limits its widespread adoption [3]. We recommend that the authors advocate for the development of specific CPT codes for ILR to improve access and reimbursement. The study briefly touches on the financial constraints faced by patients, but it could benefit from a more detailed discussion of the long-term economic burden of BCRL. A 2019 study by Dean et al. found that breast cancer survivors with lymphedema face up to 112% higher out-of-pocket costs compared to those without lymphedema, leading to reduced access to care and delayed retirement [4]. Including this data would strengthen the argument for ILR as a cost-effective preventive measure that could reduce long-term healthcare expenditures. The study identifies racial and socioeconomic disparities in access to ILR, but it could further explore the underlying factors contributing to these disparities. For example, a 2022 study by Montagna et al. found that Black and Hispanic patients are at significantly higher risk of developing BCRL after axillary lymph node dissection (ALND) and radiation therapy, independent of other risk factors [5]. This suggests that structural barriers, such as access to preventive care and insurance coverage, disproportionately affect minority populations. Including this evidence would underscore the need for targeted interventions to address these disparities. The authors acknowledge the limitations of their study, including its single-center design and qualitative assessment of lymphedema. We recommend that future research include multicenter studies with standardized diagnostic criteria for lymphedema, such as limb volume measurements or bioimpedance spectroscopy, to provide more objective data. Additionally, longitudinal studies with longer follow-up periods are needed to assess the durability of ILR in preventing BCRL. A 2019 meta-analysis by Johnson et al. found that ILR significantly reduces the risk of BCRL, but longer-term data are still lacking [6]. In conclusion, Huang et al. have provided a valuable contribution to the literature on ILR and its role in preventing BCRL. By addressing the issues of insurance coverage, socioeconomic disparities, and the need for standardized coding, this study highlights the importance of improving access to preventive surgical interventions. We believe that incorporating the additional evidence and recommendations outlined above will further strengthen the study's impact and provide a more comprehensive understanding of the barriers to ILR. The author has nothing to report. Wei Liu drafted and reviewed the article. The author declares no conflicts of interest. The author has nothing to report.